Alliance Pharma plc
APH
Delayed London Stock Exchange - 09/26 04:20:15 pm
53.25GBp
-0.47%
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 20162017
Sales97,5104
EBITDA26,028,4
Operating profit (EBIT)25,627,7
Pre-Tax Profit (EBT)22,226,2
Net income18,121,8
EPS (GBp )3,824,60
Dividend per Share (GBp )1,211,29
Yield2,55%2,40%
Announcement Date03/29/2017
07:29am
-
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 20162017
Debt76,119,8
Finance--
Operating income (EBITDA)26,028,4
Leverage
(Debt/EBITDA)
2,92x0,70x
Capital Expenditure1,132,23
Book Value Per Share (BVPS)-41,8 PNC
Cash Flow per Share--
Announcement Date03/29/2017
07:29am
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 254 M GBP -
Entreprise Value (EV) 274 M GBP 269 M GBP
Valuation 2017e 2018e
P/E ratio (Price / EPS) 11,6x 12,3x
Capitalization / Revenue 2,46x 2,31x
EV / Revenue 2,65x 2,45x
EV / EBITDA 9,64x 8,61x
Yield (DPS / Price) 2,40% 2,71%
Price to book (Price / BVPS) 1,28x 1,18x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 26,8% 27,1%
operating Leverage (Delta EBIT / Delta Sales) 1,31x 1,20x
Net Margin (Net Profit / Revenue) 21,0% 18,9%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 10,7% 9,85%
Rate of Dividend 27,9% 33,2%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   2,16% 1,71%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,70x 0,47x
Price Earning Ratio
BNA & Dividende